UPDATE: Canaccord Genuity Assumes Coverage on NPS Pharmaceuticals on Recent Market Weakness
April 16, 2014 at 09:46 AM EDT
In a report published Wednesday, Canaccord Genuity analyst John Newman assumed coverage on NPS Pharmaceuticals (NASDAQ: NPSP) with a Buy ...